Regulatory

Regulatory  ·  Weekly Digest 2
US FDA approved Zynyz for Merkel cell carcinoma

Weekly Digest – 18-24 Mar 2023 Weekly Digest – 18-24 Mar 2023 March 22, 2023: Zynyz (Retifanlimab, IV)/ Merkel Cell Carcinoma/ Incyte Corporation: Zynyz Received US FDA approval Incyte announced US FDA approval for Zynyz for the treatment of adults […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 2
FDA granted fast track designanation for Ulenistamab (PBP1510) in PDAC

Weekly Digest – 18-24 Mar 2023 Weekly Digest – 18-24 Mar 2023 March 21, 2023: Ulenistamab (PBP1510) (IV)/ Pancreatic Cancer/ Prestige Biopharma: US FDA granted fast track designation Prestige Biopharma received a fast-track designation from the US FDA for PBP1510 […]

by Sandhya Ramalingam

Continue Reading